American Society of Clinical Oncology

SHERPA: White

People

  1. Kelsen
    Kelsen
  2. Ilson
    Ilson
  3. Capanu
    Capanu
  4. Janjigian
    Janjigian
  5. Coit
    Coit
  6. Tang
    Tang
  7. Gonen
    Gonen
  8. O'Reilly
    O'Reilly
  9. Strong
    Strong
  10. Brennan
    Brennan

Groups

  1. Center for Pancreatic Cancer Research (57)
  2. Department of Medicine (56)
  3. Solid Tumor Oncology Division (55)
  4. Gastrointestinal Oncology Service (53)
  5. Epidemiology and Biostatistics (31)
  6. Biostatistics Service (30)
  7. Survivorship Research (19)
  8. Nursing (16)
  9. Surgery (16)
  10. Radiology, Department of (13)
Search Within
  1. "Manish Shah"
Formats
  1. Meeting Abstract (63)
  2. Journal Article (10)
Groups
  1. Center for Pancreatic Cancer Research (57)
  2. Department of Medicine (56)
  3. Solid Tumor Oncology Division (55)
  4. Gastrointestinal Oncology Service (53)
  5. Epidemiology and Biostatistics (31)
  6. Biostatistics Service (30)

More Groups

People
  1. Manish Shah (73)
  2. David Kelsen (50)
  3. David Ilson (26)
  4. Marinela Capanu (19)
  5. Gary Schwartz (18)
  6. Yelena Janjigian (18)

More People

Years
  1. 2015 (3)
  2. 2014 (1)
  3. 2013 (6)
  4. 2012 (3)
  5. 2011 (11)
  6. 2010 (13)

More Years

Publications
  1. Journal of Clinical Oncology (72)
  2. American Society of Clinical Oncology Educational Book (1)

Results (73)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of bevacizumab, irinotecan, cisplatin, and radiation as preoperative therapy in esophageal adenocarcinoma
    Meeting Abstract

    Ilson, D.; Goodman, K. A.; Janjigian, Y. Y.; Shah, M. A.; Kelsen, D. P.; Rizk, N. P.; Rusch, V. W.; Wu, A. J. C.; Campbell, J.; Capanu, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II trial of bevacizumab, irinotecan, cisplatin, and radiation as preoperative therapy in esophageal adenocarcinoma
    Meeting Abstract

    Ilson, D.; Goodman, K. A.; Janjigian, Y. Y.; Shah, M. A.; Kelsen, D. P.; Rizk, N. P.; Rusch, V. W.; Wu, A. J. C.; Campbell, J.; Capanu, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: A biomarker evaluation from the AVAGAST randomized phase III trial
    Journal Article

    Van Cutsem, E.; de Haas, S.; Kang, Y. K.; Ohtsu, A.; Tebbutt, N. C.; Xu, J. M.; Yong, W. P.; Langer, B.; Delmar, P.; Scherer, S. J.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Bevacizumab (Bev) plus chemotherapy for advanced gastroesophageal adenocarcinoma (GC): Combined U. S. experience
    Meeting Abstract

    Smyth, E. C.; Enzinger, P. C.; Li, J.; Vincitore, M.; Lacy, J.; El-Rayes, B. F.; Kunz, P. L.; Ford, J. M.; Robinson, E.; Kelsen, D. P.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Prognostic significance of human epidermal growth factor-2 (HER2) in advanced gastric cancer: A US and European international collaborative analysis
    Meeting Abstract

    Shah, M. A.; Janjigian, Y. Y.; Pauligk, C.; Werner, D.; Kelsen, D. P.; Jaeger, E.; Altmannsberger, H.; Robinson, E.; Tang, L. H.; Barbashina, V. V.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Survival analysis by pooling risk factors in AVAGAST: First-line capecitabine and cisplatin plus bevacizumab (bev) or placebo (pla) in patients (pts) with advanced gastric cancer (AGC)
    Meeting Abstract

    Kang, Y.; Ohtsu, A.; Van Cutsem, E.; Roman, L.; Nunes, J.; Li, C.; Otero, D.; Rivera, F.; Aprile, G.; Alvarez, P. R. P.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II trial of sorafenib in esophageal (E) and gastroesophageal junction (GEJ) cancer: Response and protracted stable disease observed in adenocarcinoma
    Meeting Abstract

    Ilson, D.; Janjigian, Y. Y.; Shah, M. A.; Kelsen, D. P.; Tang, L. H.; Campbell, J.; Fuqua, L.; Capanu, M.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II trial of sorafenib in esophageal (E) and gastroesophageal junction (GEJ) cancer: Response observed in adenocarcinoma
    Meeting Abstract

    Ilson, D.; Janjigian, Y. Y.; Shah, M. A.; Tang, L. H.; Kelsen, D. P.; Campbell, J.; Fuqua, L.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Positron emission tomography (PET) with (89)Zr-labeled trastuzumab ((89)Zr-trastuzumab): Monitoring HER2 expression in HER2-positive gastric cancer in vivo
    Meeting Abstract

    Janjigian, Y. Y.; Villegas, N. T.; Holland, J. P.; Shah, M. A.; Divilov, V.; Kelsen, D. P.; Lewis, J. S.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Quality of life in patients with advanced gastroesophageal (GE) adenocarcinoma treated with modified docetaxel, cisplatin, and fluorouracil (mDCF)
    Meeting Abstract

    Smyth, E. C.; Janjigian, Y. Y.; Robinson, E.; Sheehy, E. C.; Karpenko, I.; Capanu, M.; Kelsen, D. P.; Shah, M. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save